HSBC TUR.WAR.OP.END. RGO/ DE000HS2S927 /
20/06/2024 8:01:56 | Diferencia0.0000 | Bid8:11:22 | Ask8:11:22 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
2.0900EUR | 0.00% | 2.0800 Volumen de oferta: 25,000 |
2.1500 Tamaño/ Volumen/ Formato de Ask: 25,000 |
Regeneron Pharmaceut... | 819.25 USD | 31/12/2078 | Call |
GlobeNewswire
8:10
IDEX Biometrics secures repeat order for IDEX Access from AuthenTrend for new markets
GlobeNewswire
7:33
Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order
GlobeNewswire
7:30
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of I...
GlobeNewswire
7:15
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
GlobeNewswire
7:00
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids a...
GlobeNewswire
7:00
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids a...
GlobeNewswire
7:00
Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting
GlobeNewswire
7:00
Technip Energies awarded a significant contract for IOCL’s grassroots naphtha cracking unit at Parad...
Newsfile Corp
6:47
Monarch Equity Capital Berhad Signs MoA with DR.IP Strategy Partner of Universiti Malaya Centre for ...
GlobeNewswire
6:36
OKX to Become First in CeFi to Launch AI-Powered Automated Trading Platform, Celebrates with 'Smart ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página